_how-early-and-aggressive-lowering-of-apob-could-change-the-course-of-ascvd-124-the-peter-attia-drive-preview-1.jpg "How early and aggressive lowering of apoB could change the course of ASCVD | The Peter Attia Drive from apob Video Screenshot Preview 1")
Gallery_how-early-and-aggressive-lowering-of-apob-could-change-the-course-of-ascvd-124-the-peter-attia-drive-preview-3.jpg "How early and aggressive lowering of apoB could change the course of ASCVD | The Peter Attia Drive from apob Video Screenshot Preview 3")
Gallery_how-early-and-aggressive-lowering-of-apob-could-change-the-course-of-ascvd-124-the-peter-attia-drive-preview-hqdefault.jpg "How early and aggressive lowering of apoB could change the course of ASCVD | The Peter Attia Drive from apob Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 4 minutes 37 seconds
👁 View: 38.6K times
Play Audio:👁 View: 38.6K times
Description:
Peter Attia MD
Peter Attia MD
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_cardiovascular-disease-amp-why-we-should-change-the-way-we-assess-risk-124-the-peter-attia-drive-podcast.webp "Peter Attia MD")
Cardiovascular disease & why we should change the way we assess risk | The Peter Attia Drive Podcast
⏲ 2 hours 25 minutes 35 seconds 👁 133.3K
_ldl-cholesterol-is-useless-measure-this-instead-apob.webp "High Intensity Health")
_motivation-apob-blood-tests.webp "Motivation APOB blood tests from apob")
_apob-ldl-and-lpa-my-perspective-part-1.webp "Dr. Ford Brewer MD MPH - PrevMed Health")
_genomics-to-identify-new-risk-factors-for-hcc-development.webp "Presenter: Eric Letouzé, PhD (France)nnLiver cancers mostly develop in a context of liver disease related to various etiologies including viral infection, alcohol abuse or metabolic syndrome. In the last 5 years, our team and others have used genomic profiling to (1) identify new risk factors for cases of unknown etiology, and (2) better understand how the interplay of risk factors and endogenous cellular processes reshape the genomes of liver cancer cells. Using viral capture and next-generati")
_elevated-lipoprotein-little-a-what39s-the-best-treatment-for-lpa.webp "HealthspanMD")
⏲ 18 minutes 19 seconds 👁 17.9K
_dave-feldman-presentation-apob-cholesterol-and-the-lean-mass-hyper-responders-research-update.webp "Low Carb Conferences")
⏲ 36 minutes 38 seconds 👁 33.1K
_the-apob-cholesterol-test-better-than-92.webp "The apoB Cholesterol Test: Better than \ from apob")
_cardiovascular-disease-amp-why-we-should-change-the-way-we-assess-risk-124-the-peter-attia-drive-podcast.jpg)
_ldl-cholesterol-is-useless-measure-this-instead-apob.jpg)
_motivation-apob-blood-tests.jpg)
_apob-ldl-and-lpa-my-perspective-part-1.jpg)
_genomics-to-identify-new-risk-factors-for-hcc-development.jpg)
_elevated-lipoprotein-little-a-what39s-the-best-treatment-for-lpa.jpg)
_dave-feldman-presentation-apob-cholesterol-and-the-lean-mass-hyper-responders-research-update.jpg)
_the-apob-cholesterol-test-better-than-92.jpg)
![[+]](/images/menu.gif){kind=small}